Next-gen therapies for cancer and dementia fast-tracked with new facility
By Liz Wells 28 August 2025
The UK government is to invest £29.6m in a new facility that will springboard new RNA therapies, which could help tackle cancer, heart conditions, and other diseases.
Senior Lawyer (Adults) - 37 Hours
£55,437 to £58,525 includes a market supplement of £8,256 per year
Torbay, Devon£55,437 to £58,525 includes a market supplement of £8,256 per year
Children's Home Residential Practitioner (Bank Staff)
£30,024 - £32,597 per annum
Gloucester, Gloucestershire£30,024 - £32,597 per annum
Advanced Practitioner
£48,226 - £51,356 per annum
Gloucester, Gloucestershire£48,226 - £51,356 per annum
Most Read News
- MHRA approves UK's first oral GLP-1
- NHS ConfedExpo: Murray offers 'not a change of course but a change of gear'
- EXCLUSIVE: NHS heroes recognised after accelerating cancer diagnosis and transforming patient care
- Nurse struck off for falsifying shift records
- NHS Confed Expo: Is the US drug deal good or bad for the NHS?
Senior Lawyer (Adults) - 37 Hours
£55,437 to £58,525 includes a market supplement of £8,256 per year
Torbay, Devon£55,437 to £58,525 includes a market supplement of £8,256 per year
Children's Home Residential Practitioner (Bank Staff)
£30,024 - £32,597 per annum
Gloucester, Gloucestershire£30,024 - £32,597 per annum
Advanced Practitioner
£48,226 - £51,356 per annum
Gloucester, Gloucestershire£48,226 - £51,356 per annum
Most Read News
- MHRA approves UK's first oral GLP-1
- NHS ConfedExpo: Murray offers 'not a change of course but a change of gear'
- EXCLUSIVE: NHS heroes recognised after accelerating cancer diagnosis and transforming patient care
- Nurse struck off for falsifying shift records
- NHS Confed Expo: Is the US drug deal good or bad for the NHS?
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
